About us

A united institute

The UK Dementia Research Institute (UK DRI) is a joint £290 million investment from the Medical Research Council (MRC), Alzheimer’s Society and Alzheimer’s Research UK.

The UK DRI breaks new ground by bringing together world-leading expertise in biomedical, care and translational dementia research in a national institute. The institute will grow to be made up of 700 scientists carrying out a rich, varied and integrated programme of research.  

The institute will carry out research relevant to all dementias, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, vascular dementia, Huntington’s disease and beyond.

Working together to understand the complex mechanisms of dementias

Centred on the need for innovative, early-stage science to advance our understanding of how dementias develop and progress, the UK DRI’s research will bring new therapies to patients faster. The institute’s mission is to find new ways to diagnose, treat and prevent dementias, whilst finding better ways to provide care for people with dementia.

The success of the UK DRI depends on the people in it. The institute is structured so that its researchers are connected, wherever their labs are based. Having centres located across the UK allows the institute to bring people together for shared scientific inspiration, whilst making the most of cutting-edge tools and infrastructure locally.

Our hub and each centre has an associate director, and every person working in the UK DRI contributes towards achieving the institute’s vision. Care research will also be integrated into the institute in 2018.

Connecting to the UK landscape

We want the UK DRI to make a big impact, but we know the institute can’t transform the outlook for people with dementia on its own. The institute will build on and connect to the strong dementia research landscape that exists across the UK. In particular, the UK DRI will connect to the strengths of the MRC Dementias Platform UK (DPUK), the NIHR Translational Collaboration in Dementia Research and the recent Momentum research awards for dementia. The UK DRI will also align with charity-led initiatives such as the Alzheimer’s Research UK’s Drug Discovery Alliance, and Brains for Dementia Research which is funded by Alzheimer’s Society, Alzheimer’s Research UK and the MRC. 

The UK DRI is not working alone; it will carry on proactively seeking additional charity, industry, national and international partners in delivering its mission. We have a very open policy with regard to our results, and proactively seek ways to share our work and its impact through our networks and partners including NeuroCentral

Founding funders

Latest tweets from @UKDRI

Congratulations to this year's @brkthroughprize winners, on incredible work progressing their fields. We're super… https://t.co/Nitl1ECPyI
17 Oct 2018 16:31

RT @DipeshGopal: Really exciting to see #innovation in #dementia #Research and how the #Formula1 industry can help #medicine. So unusual th…
17 Oct 2018 10:58